SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000059478-21-000117
Filing Date
2021-04-27
Accepted
2021-04-27 06:48:39
Documents
16
Period of Report
2021-04-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lly-20210427.htm   iXBRL 8-K 63150
2 EX-99.1 q121lillysalesandearningsp.htm EX-99.1 329531
8 logoa311.jpg GRAPHIC 14287
  Complete submission text file 0000059478-21-000117.txt   676282

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20210427.xsd EX-101.SCH 4267
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20210427_cal.xml EX-101.CAL 715
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20210427_def.xml EX-101.DEF 18480
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20210427_lab.xml EX-101.LAB 38670
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20210427_pre.xml EX-101.PRE 19470
9 EXTRACTED XBRL INSTANCE DOCUMENT lly-20210427_htm.xml XML 25252
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 21855813
SIC: 2834 Pharmaceutical Preparations